Stockscreener 앱 받기
1.49
1.36%
0.02
시간 외 거래:
1.49
전일 마감가:
$1.47
열려 있는:
$1.46
하루 거래량:
76,909
Relative Volume:
0.34
시가총액:
$3.00M
수익:
-
순이익/손실:
$-9.34M
주가수익비율:
-0.2087
EPS:
-7.14
순현금흐름:
$-6.69M
1주 성능:
+2.76%
1개월 성능:
+15.50%
6개월 성능:
-58.26%
1년 성능:
-83.75%
1일 변동 폭
$1.4405
$1.52
1주일 범위
$1.44
$1.55
52주 변동 폭
$1.25
$16.63
패인리폼 Stock (PRFX) Company Profile
PRFX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRFX
Painreform Ltd
|
1.49 | 2.96M | 0 | -9.34M | -6.69M | -7.14 |
|
ZTS
Zoetis Inc
|
152.12 | 68.04B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.48 | 46.30B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.88 | 44.25B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.54 | 18.73B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
304.50 | 13.82B | 2.99B | 1.21B | 1.13B | 25.06 |
패인리폼 주식(PRFX)의 최신 뉴스
Is PainReform Ltd. stock overvalued or undervaluedStay informed with daily expert analysis - jammulinksnews.com
Should I hold or sell PainReform Ltd. stock in 2025Get timely advice on market trends - jammulinksnews.com
How volatile is PainReform Ltd. stock compared to the marketInvest smarter with data-backed insights - jammulinksnews.com
Why is PainReform Ltd. stock attracting strong analyst attentionRapidly growing investment returns - jammulinksnews.com
PainReform Ltd. Stock Support and Resistance Levels You Should KnowROI Focused Stock Calls - Newser
Key External Factors That Drive PainReform Ltd. Stock Price MovementsFree Stock Trading Community - Newser
What analysts say about PainReform Ltd. stockHigh-yield market plays - PrintWeekIndia
What makes PainReform Ltd. stock attractive to long term investorsFree Stock Market Return Analysis - jammulinksnews.com
What analysts say about PainReform Ltd. stock outlookUnmatched profit growth - jammulinksnews.com
Why PainReform Ltd. stock attracts strong analyst attentionTechnical Breakout List - Newser
Painreform Shares Drop 11% After Revealing Strategic Stake in LayerBio - MSN
What drives PainReform Ltd. stock priceExceptional profit potential - Autocar Professional
Is PainReform Ltd. a good long term investmentUnmatched market performance - Autocar Professional
PainReform Ltd. Stock Analysis and ForecastGame-changing capital returns - jammulinksnews.com
Is PainReform Ltd. stock overhyped or has real potentialFree Day Trading Recommendations - Newser
What makes PainReform Ltd. stock price move sharplyWealth Building Stock Portfolio - Newser
How PainReform Ltd. stock performs during market volatilityFree Popular Stock Recommendations - Newser
PainReform (NASDAQ:PRFX) Trading Up 0.7% – Here’s Why - Defense World
PainReform Ltd. enters into a Strategic Investment - GlobeNewswire
LayerBio, Inc. announced that it expects to receive $3 million in funding from PainReform Ltd. - MarketScreener
LayerBio, Inc. announced that it expects to receive $2.95 million in funding from PainReform Ltd. - MarketScreener
Painreform stock falls after announcing strategic investment in LayerBio By Investing.com - Investing.com Australia
PainReform invests in LayerBio to expand into ophthalmology By Investing.com - Investing.com South Africa
PainReform Expands into Ophthalmology with Strategic Investment in LayerBio - TipRanks
PRFX SEC FilingsPainreform Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
패인리폼 (PRFX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.82%
0.27%
자본화:
|
볼륨(24시간):